Treatment for kaanakadi (Papular Urticaria) - An oral administration of siddha medicine Poovarasam pattai(THESPESIA POPULNEA) kudineer.

A CASE SERIES ON KAANAKADI (PAPULAR URTICARIA) TREATING WITH POOVARASAM (THESPESIA POPULNEA) PATTAI KUDINEER. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071332

Enrollment

Registered

2024-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

Intervention1: Poovarasam pattai kudineer.: Dosage: 50ML (Twice a day), Before food for 7 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have symptoms of itching, wheel formation and swelling. 2.Patients who are willing to give blood sample for laboratory investigations.

Exclusion criteria

Exclusion criteria: 1.Pregnancy and Lactating women. 2.Evidence of any skin disease other than urticaria. 3.Patient with diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
Prognosis of kaanakadi(Papular Urticaria) will be assessed by clinical symptoms, blood investigation of the patients (before and after treatment).Timepoint: 7 days	—

Secondary

Measure	Time frame
The secondary outcome will be diagnosis of the disease with the observation of siddha diagnostic parametersTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr. M. P. Abdul Kader Jeylani

Government siddha medical College

drjeylani@gmail.com9486272548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026